act genomics dinner symposium | moving from brca1/2 to hrd: beyond woman’s cancers
Published 4 years ago • 741 plays • Length 2:01:14Download video MP4
Download video MP3
Similar videos
-
29:07
actg dinner symposium highlights | beyond brca testing – does hrd matter? | prof michael friedlander
-
39:15
actg dinner symposium highlights | brca testing – old story, new opportunities | dr shaheenah dawood
-
30:36
actg dinner symposium highlights | clinical case sharing - real world evidence | a/prof lee soo chin
-
35:40
understanding brca 1/2 cancer risk | dana-farber cancer institute
-
8:37
brca1 and brca2 mutations & cancer (types of cancer, and who’s most at risk)
-
1:01:28
breast cancer & genomics: brca & beyond
-
4:09
doctor explains brca1 & brca2 genetic testing for inherited breast and ovarian cancer...
-
3:31
brca1 and brca2 genetic testing panel overview | ambry genetics
-
43:31
probably nothing: brca and ovarian cancer
-
1:51
brca and rab: prognostic biomarkers in recurrent ovarian cancer
-
51:49
webinar: genetics and genomics for ovarian cancer - march 1, 2021
-
2:49
brca1 - tales from the genome
-
6:27
brca across tumour types
-
22:15
a spotlight on: genetic counselling and brca testing - grace kavanaugh
-
2:16
brca gene therapy
-
40:45
mbc alliance webinar - hereditary breast cancer & genetic testing
-
4:42
treatment of hrd-negative ovarian cancer
-
21:06
brca testing - who needs it?
-
0:53
gynecologic oncology: brca genes